论文部分内容阅读
浅表性膀胱癌的显著特征是复发率高和肿瘤进展危险性低。尿细胞学和膀胱镜检查一直是膀胱癌的主要检查方法。几种新的瘤标 ,包括膀胱肿瘤抗原 (BTA)系列、NMP2 2和 FDP,已经开始在临床上试用 ,目前尚有其他瘤标正处于评估阶段。这些瘤标有助于检测出临床隐匿性膀胱癌并延长膀胱
The salient features of superficial bladder cancer are high recurrence rates and low risk of tumor progression. Urine cytology and cystoscopy have been the primary screening methods for bladder cancer. Several new tumor targets, including the Bladder Tumor Antigen (BTA) series, NMP2 2 and FDP, have been in clinical trials and there are other tumor targets currently under evaluation. These knobs help detect clinically occult bladder cancer and extend the bladder